The Parking Lot Prostate Exam Project #TalkProstate
To stimulate public discussion about prostate cancer and the importance of early detection, Prostate Cancer Canada teamed up with FCB Canada and CFL legend Damon Allen during Prostate Cancer Awareness Month to help get a serious message across through a fun campaign.
Interpreting the study on early prostate cancer survival with Urologist and prostate cancer expert, Dr. Fred Saad
Toronto, ON – September 19, 2016: A study published last week in the New England Journal of Medicine followed men with localized (contained to the prostate) prostate cancer for 10 years as they underwent one of three randomized treatment streams has since been widely reported on. Notably, many of the headlines touched upon the same reassuring conclusion: whether participants were treated with radiation therapy, had their prostates removed altogether, or were simply monitored using Prostate-Specific Antigen (PSA) tests, survival after ten years was the same at 99 per cent.
The future of prostate cancer research looks bright
Toronto, ON – September 19, 2016: Continuing with its ongoing commitment to ensure the future of prostate cancer research in Canada is left in the best possible hands, Prostate Cancer Canada (PCC) has chosen four postdoctoral fellows and one PhD candidate as the recipients for this year’s prestigious personnel awards.
Plaid for Dad becoming a Canadian Father's Day tradition
July 8, 2016 – TORONTO, ON – In only its second year, Prostate Cancer Canada’s (PCC) Plaid For Dad campaign further solidified itself as the way Canadians are choosing to give back each Father’s Day weekend. Growing from 200 to over 600 participating workplaces across the country, the number of Canadians who wore plaid to raise awareness and research funds for prostate cancer rose significantly in just a year’s time.
A Walk to Remember
CALGARY, ALBERTA – June 20th, 2016 – Friends, families and survivors from across the country joined Prostate Cancer Canada this Father’s Day, unified by one goal – to raise funds and awareness for prostate cancer.
Team Eberle, led by Jordan Eberle of the Edmonton Oilers, show their enthusiasm at the Calgary Walk Run.
#PlaidForDad Sweeps the Nation
JUNE 17TH, 2016 – TORONTO, ON – After a successful inaugural year that yielded over 200 Canadian workplaces and evolved into a wide scale social media movement, #PlaidforDad has returned in a big way to raise research funds and awareness for the most common cancer in men. Over 600 workplaces across all sectors representing hundreds of thousands of individuals across Canada are wearing Plaid for Dad today to do their part in raising vital research funds to improve the way we detect, treat and support Canadian men and their families faced with the disease.
Active surveillance pioneer seeks to improve prostate cancer biopsies
The man who is credited with coining the term active surveillance, Dr. Laurence Klotz of the Sunnybrook Research Institute, is leading a team focused on improving the way we biopsy for prostate cancer. The Movember Foundation, the Ontario Institute for Cancer Research (OICR) and Prostate Cancer Canada today announced, in partnership, $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer. The primary objective of the multi-centre trial, called PRECISE, is to determine whether MRI imaging can spare some men from undergoing a biopsy and avoid the possible associated side effects.
Canadians Encouraged to Wear Plaid for Dad before Father’s Day
TORONTO, ON – (May 12, 2016) – This morning marked the launch of Canada’s second annual Plaid for Dad campaign in support of Prostate Cancer Canada (PCC). To formally announce the start of the campaign, Vice-Admiral Mark Norman, Commander of the Royal Canadian Navy, arrived at the shores of Toronto’s harbourfront aboard a naval ship waving official plaid flags.
Prostate Cancer Canada research aims to further our understanding of subcategory of men with prostate cancer
TORONTO, ON – May 10, 2016 —Prostate Cancer Canada (PCC) has awarded research funding to Dr. Murray Krahn of the University Health Network of Toronto to improve what is known about a subgroup of men with non-metastatic castration-resistant prostate cancer (nmCRPC) – i.e. men with a rising prostate-specific antigen (PSA) level after treatment with standard forms of androgen deprivation therapy (ADT), but no clear evidence that the disease has spread in bone or CT scans.